障碍与蓝图：胃肠道肿瘤中 CAR-T 细胞治疗的下一代工程策略

Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors.

Claudin18.2 阳性胃癌的临床试验全景

The Landscape of Clinical Trials for Claudin18.2-Positive Gastric Cancer.

CLDN18.2 已成为胃癌靶向治疗的重要新靶点。

从实验台到临床：实体恶性肿瘤 CAR-T 细胞治疗的新兴范式

From Bench to Bedside: Emerging Paradigms in CAR-T Cell Therapy for Solid Malignancies.

嵌合抗原受体（CAR）免疫细胞治疗胃癌的新方法：聚焦 CAR-T 与 CAR-NK

New approaches of chimeric antigen receptor (CAR)-immune cell-based therapy in gastric cancer; highlight CAR-T and CAR-NK.

mRNA 递送在肿瘤免疫治疗中的应用

Applications of mRNA Delivery in Cancer Immunotherapy.

嵌合细胞因子受体 TGF-β RⅡ/IL-21R 通过逆转胃癌免疫抑制性肿瘤微环境改善 CAR-NK 细胞功能

Chimeric cytokine receptor TGF-β RⅡ/IL-21R improves CAR-NK cell function by reversing the immunosuppressive tumor microenvironment of gastric cancer.

构建更好的防御：扩增与改进 NK 细胞用于过继细胞疗法

Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.

NK 细胞治疗：肥胖相关癌症的新前沿

Natural killer cell therapy: A new frontier for obesity-associated cancer.